Clinical trial
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
NCT01040624
Study timeline
Study start (unknown)2009-12-01Date precision: month
Registry last updated2023-10-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
< 15% risk of + LNRADIATION
> 15% risk of + LNRADIATION
Sponsors & collaborators
University of Floridalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01040624 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.